Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Paragon Care's share price for the quarter that ended in Dec. 2025 was A$0.215. Paragon Care's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 1,655 Mil. Therefore, Paragon Care's market cap for the quarter that ended in Dec. 2025 was A$356 Mil.
Paragon Care's quarterly market cap
declined
from Dec. 2024 (A$795 Mil) to Jun. 2025 (A$604 Mil) and
declined
from Jun. 2025 (A$604 Mil) to Dec. 2025 (A$356 Mil).
Paragon Care's annual market cap
increased
from Jun. 2023 (A$155 Mil) to Jun. 2024 (A$728 Mil) but then
declined
from Jun. 2024 (A$728 Mil) to Jun. 2025 (A$604 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Paragon Care's Enterprise Value for Today is A$582 Mil.
Paragon Care (ASX:PGC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Paragon Care Market Cap Related Terms
Paragon Care Market Cap Historical Data
* Premium members only.
The historical data trend for Paragon Care's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Paragon Care's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's Market Cap distribution charts can be found below:
* The bar in red indicates where Paragon Care's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Paragon Care's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon Care (ASX:PGC) has a Market Cap of A$215 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Paragon Care and its competitors. According to the industry distribution chart, Paragon Care ranks #60 out of 120 companies in the Medical Distribution industry, placing it in the top 50%.
Is Paragon Care's Market Cap too high?
Paragon Care's current Market Cap is A$215 Mil. Based on the distribution chart, Paragon Care ranks #60 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Paragon Care has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Paragon Care ranks #60 out of 120 companies for Market Cap. This puts Paragon Care in the upper half of its industry. The industry median Market Cap is 145.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 145.30, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Paragon Care and its competitors. For the Medical Distribution industry, the median Market Cap is 145.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paragon Care's current Market Cap is A$215 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (ASX:PGC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.14 — trading 66.3% below its estimated fair value. The current Market Cap is A$215 Mil. Paragon Care's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Paragon Care (ASX:PGC), the current Market Cap is A$215 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (ASX:PGC) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of A$0.14 is trading 66.3% below its estimated GF Value™ of A$0.40.
GuruFocus considers Paragon Care to be Possible Value Trap.
Key valuation signals for ASX:PGC:
Market Cap: A$215 Mil
GF Value™: A$0.40 vs. price of A$0.14 (66.3% below fair value)
No single metric tells the full story. See the ASX:PGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
56GF Score
Get the complete analysis for ASX:PGC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PGC has been successfully added to your 
